| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | SENARAI UBAT YANG DIKECUALIKAN DARI PERMOHONAN UKK | TARIKH KEMASKINI: 5 JAN 2026 | |||||||||||||||||||||
2 | Surat Pengecualian ini boleh dicapai melalui: 1. Intranet Pharmacy: • Dashboard » Community » Bahagian Amalan dan Perkembangan » Cawangan Pengurusan Formulari • Dashboard » Community » Cawangan Pengurusan Formulari » Seksyen Ubat Khas 2. Aplikasi MyFormulary (perlu login menggunakan akaun intranet dan pilih “Circulars”) | ||||||||||||||||||||||
3 | NAMA UBAT | INDIKASI | SYARAT TAMBAHAN | NO. RUJ. SURAT | TARIKH SURAT | CATATAN | |||||||||||||||||
4 | Acetazolamide 250mg Tablet | i) Catamenial epilepsy ii) Idiopathic intracranial hypertension | KKM.600-34/4/15 Jld. 5 (08) | 06/09/2024 | |||||||||||||||||||
5 | Acetazolamide 250mg Tablet | To reduce intraocular pressure post cataract surgery. | KKM.600-34/4/15 Jld. 6 (1) | 29/12/2025 | |||||||||||||||||||
6 | Acetylcysteine 200mg/ml injection | Non-PCM-induced acute liver failure | - | KKM-55/BPF/103/001/09 Jld. 16(41) | 21/04/2016 | ||||||||||||||||||
7 | Acetylsalicylic Acid 100mg/Glycine 45mg Tablet | i) Post percutaneous coronary intervention ii) Post-myocardial infarction iii) Prevention of pre-eclampsia in pregnant woman with risk factors | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
8 | Acetylsalicylic Acid 150mg Tablet Acetylsalicylic Acid 75mg Tablet | Initial treatment of cardiovascular disorders such as angina pectoris and myocardial infarction and for the prevention of cardiovascular events in patients at risk. Other such uses include the treatment and prevention of cerebrovascular disorders such as stroke | - | KKM.600-34/4/15 Jld.4(23) | 12/10/2022 | Telah tersenarai dalam FUKKM pada tahun 2023 | |||||||||||||||||
9 | Acetylsalicylic Acid 150mg Tablet Acetylsalicylic Acid 75mg Tablet | Prevention of pre-eclampsia in pregnant women with risk factors | KKM.600-34/4/15 Jld. 5 (08) | 06/09/2024 | |||||||||||||||||||
10 | Acetylsalicylic Acid 300mg Soluble Tablet* | Prevention of pre-eclampsia in pregnant woman with risk factors. | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
11 | Acetylsalicylic Acid 300mg Soluble Tablet | Treatment for pericarditis | KKM.600-34/4/15 Jld. 6 (1) | 29/12/2025 | |||||||||||||||||||
12 | Acitretin 10mg Capsule Acitretin 25mg Capsule | i) Hypertrophic lichen planus ii) Mycosis fungoides | KKM.600-34/4/15 Jld. 5 (08) | 06/09/2024 | |||||||||||||||||||
13 | Acitretin 10mg Capsule | Hidradenitis suppurativa | KKM.600-34/4/15 Jld. 6 (1) | 29/12/2025 | |||||||||||||||||||
14 | Adalimumab 40mg Injection | i) Treatment of refractory Behcet's disease (BD) with suboptimal control. ii) Treatment of adult-onset Still's disease | KKM.600-34/4/15 Jld. 6 (1) | 29/12/2025 | |||||||||||||||||||
15 | Adenosine 3 mg/ml Injection | Pharmacological heart stressor agent for Stress Test in patient who cannot exercise | KKM.600-34/4/15 Jld. 5 (08) | 06/09/2024 | |||||||||||||||||||
16 | Adrenaline 1mg (1:1000) Injection | Adjunct therapy in: Acute upper airway obstruction | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | For nebulization/ endotracheal/ endobronchial | |||||||||||||||||
17 | Adrenaline Acid Tartrate 1mg/ml injection | Septic shock | - | KKM-55/BPF/103/001/09 Jld. 16(41) | 21/04/2016 | ||||||||||||||||||
18 | Alteplase 50mg per vial Injection | Prosthetic valve thrombosis | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
19 | Alteplase 50mg per vial Injection | Kawasaki disease with giant coronary aneurysm and thrombus, as thrombolytic agent to prevent myocardial infarction and death (*Reserved for patients with coronary artery aneurysm thrombosis, particularly if occlusive) | - | KKM.600-34/4/15 Jld. 5 (08) | 06/09/2024 | ||||||||||||||||||
20 | Alteplase 50mg per vial Injection | i) Treatment of intra-pleural fibrinolysis in complicated parapneumonic effusion and empyema. | KKM.600-34/4/15 Jld. 6 (1) | 29/12/2025 | |||||||||||||||||||
21 | Amantadine HCl 100 mg Tablet | i) Improve consciousness (arousal) and cognitive function (attention and memory deficits) in comatose adult acquired brain injury patients. ii) Improve consciousness in children post traumatic brain injury. | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
22 | Amikacin 250mg/ml Injection Amikacin 125mg/ml Injection | Treatment of Non-tuberculous Mycobacteria (NTM) other than skin & soft tissue (SSTI) NTM | KKM.600-34/4/15 Jld. 5 (17) | 23/12/2024 | |||||||||||||||||||
23 | Amitriptyline HCl 25 mg Tablet | Neuropathic pain | - | KKM-55/BPF/103/001/09 Jld. 16(41) | 21/04/2016 | ||||||||||||||||||
24 | Amitriptyline HCL 25mg Tablet | Sialorrhea for motor neuron disease and Parkinson's disease | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
25 | Amitriptyline HCL 25mg Tablet | Migraine prophylaxis | KKM.600-34/4/15 Jld. 5 (08) | 06/09/2024 | |||||||||||||||||||
26 | Amlodipine 5mg Tablet Amlodipine 10mg Tablet | Low dose used as vasodilator in patients with Raynaud’s phenomenon | KKM.600-34/4/15 Jld. 5 (17) | 23/12/2024 | |||||||||||||||||||
27 | Amoxicillin 1000 mg/Clavulanate 200 mg Injection | Surgical prophylaxis - plastic surgery | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
28 | Amoxicillin 1000 mg/Clavulanate 200 mg Injection | Surgical prophylaxis - urological surgery | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
29 | Amoxicillin 500 mg/Clavulanate 125 mg Tablet | Surgical prophylaxis - vascular surgery | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
30 | Amoxicillin 500 mg/Clavulanate 125 mg Tablet | Surgical prophylaxis - general surgery | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
31 | Amphotericin B 50mg Injection* | Adjunct treatment of fungal endophthalmitis (used as intravitreal injection) | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
32 | Antithymocyte immunoglobulin (horse) + (Rabbit) | As a second line treatment option of anaemia in young, low risk Myelodysplastic syndromes (MDS) patients without Chromosome 5q deletion syndrome (del (5q)) | KKM.600-34/4/15 Jld. 5 (08) | 06/09/2024 | |||||||||||||||||||
33 | Apixaban 2.5mg Film Coated Tablet, Apixaban 5mg Film Coated Tablet | Left Ventricular thrombus in patients who cannot tolerate warfarin | KKM.600-34/4/15 Jld. 5 (08) | 06/09/2024 | |||||||||||||||||||
34 | Apixaban 2.5mg Film Coated Tablet, Apixaban 5mg Film Coated Tablet | i) For stroke prevention with atrial flutter. ii) Paroxysmal atrial fibrillation in end stage renal failure. iii) Cancer associated thrombosis (CAT). | KKM.600-34/4/15 Jld. 6 (1) | 29/12/2025 | |||||||||||||||||||
35 | Aripiprazole 10mg Tablet Aripiprazole 15mg Tablet | i. Behavioural Addiction ii. Agitation and Aggression in patients with substance use disorder | KKM.600-34/4/15 Jld. 5 (17) | 23/12/2024 | |||||||||||||||||||
36 | Aripiprazole 10mg Tablet Aripiprazole 15mg Tablet | Agitation/ aggression and psychosis associated with dementia, severe or refractory | KKM.600-34/4/15 Jld.5(22) | 22/03/2025 | |||||||||||||||||||
37 | Arsenic Trioxide 1 mg/ml Injection | As first line in high risk acute promyelocytic leukemia (APML) | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
38 | Atropine sulphate 1% Eye Drops | Sialorrhea for paediatric and adult neurology patients (sublingual administration of atropine eye drops) | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
39 | Azathioprine 50mg Tablet | Atopic eczema | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
40 | Azithromycin 250mg Tablet | Typhoid fever | Resistance to ciprofloxacin | KKM.600-34/4/15.Jld.4(20) | 02/09/2022 | ||||||||||||||||||
41 | Azithromycin 250mg Tablet | COPD patient (non-current smoker) who still have exacerbation despite on Long-acting bronchodilator inhalers (LABA)+ Long-Acting Muscarinic Antagonist (LAMA) + Inhaled corticosteroids (ICS) | KKM.600-34/4/15 Jld. 5 (08) | 06/09/2024 | |||||||||||||||||||
42 | Azithromycin 250mg Tablet | Asthma patient with persistent symptomatic asthma despite high dose Inhaled corticosteroids (ICS)/ Long-acting bronchodilator inhalers (LABA). | KKM.600-34/4/15 Jld. 5 (08) | 06/09/2024 | |||||||||||||||||||
43 | Azithromycin 250mg Tablet | For patient with stable bronchiectasis | KKM.600-34/4/15 Jld. 5 (08) | 06/09/2024 | |||||||||||||||||||
44 | Azithromycin 250mg Tablet | Untuk merawat dan mencegah penyakit Yaws | KKM.600-34/4/15 Jld. 5 (35) | 10/09/2025 | Indikasi telah tersenarai dalam FUKKM pada 24/12/2025 (Pindaan Pekeliling FUKKM Bil. 3/2025) | ||||||||||||||||||
45 | Azithromycin 250mg Tablet Azithromycin 500mg Injection | Mycobacterium Avium Complex (MAC) Treatment | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
46 | Azithromycin 250mg Tablet Azithromycin 500mg Injection | Rhodococcus Treatment | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
47 | Azithromycin 250mg Tablet Azithromycin 500mg Injection | Camplyobacter jejuni | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
48 | Azithromycin 250mg Tablet Azithromycin 500mg Injection | Salmonella, non-typhi | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
49 | Azithromycin 250mg Tablet Azithromycin 500mg Injection | Vibrio cholera | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
50 | Azithromycin 250mg Tablet Azithromycin 500mg Injection | Shigella sp. | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
51 | Azithromycin 250mg Tablet Azithromycin 500mg Injection | Travellers’ diarrhoea | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
52 | Azithromycin 250mg Tablet Azithromycin 500mg Injection | Treatment of syphilis in pregnancy | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
53 | Azithromycin 250mg Tablet Azithromycin 500mg Injection | Treatment of chancroid (Haemophilus ducreyi) | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
54 | Azithromycin 250mg Tablet Azithromycin 500mg Injection | Treatment of lymphogranuloma venereum | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
55 | Azithromycin 250mg Tablet Azithromycin 500mg Injection | Treatment of granuloma inguinale | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
56 | Azithromycin 250mg Tablet Azithromycin 500mg Injection | Treatment of scrub typhus | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
57 | Azithromycin 250mg Tablet Azithromycin 500mg Injection | Treatment of leptospirosis | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
58 | Azithromycin 250mg Tablet Azithromycin 500mg Injection | Prophylaxis for household and close contracts of meningococcal meningitis cases | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
59 | Azithromycin 250mg Tablet Azithromycin 500mg Injection | Acute otitis media | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
60 | Azithromycin 250mg Tablet Azithromycin 500mg Injection | Pelvic inflammatory disease | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
61 | Azithromycin 250mg Tablet Azithromycin 500mg Injection | Surgical termination of pregnancy (prophylaxis) | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
62 | Azithromycin 250mg Tablet Azithromycin 500mg Injection | Ocular toxoplasmosis (Toxoplasmosis Gondii) | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
63 | Azithromycin 250mg Tablet | i. Prophylaxis for graft-versus-host disease (GVHD) in hematopoietic stem cell transplantation ii. Treatment of Non-tuberculous Mycobacteria (NTM) other than skin & soft tissue (SSTI) NTM | KKM.600-34/4/15 Jld. 5 (17) | 23/12/2024 | |||||||||||||||||||
64 | Baricitinib 2mg dan 4mg Tablet | Untuk rawatan jangkitan Covid-19 bagi pesakit di fasiliti Kementerian Kesihatan Malaysia | - | KKM.600-34/4/15 Jld.3(63) | 16/07/2021 | Pengecualian ini akan terbatal sekiranya penggunaan ubat-ubatan tersebut telah dikeluarkan daripada garis panduan Clinical Management of Confirmed Covid-19 Case in Adult and Paediatric (Annex 2e) [versi terkini] | |||||||||||||||||
65 | Beclomethasone Dipropionate 100mcg/dose Inhaler* Beclomethasone Dipropionate 200 mcg/dose Inhaler* | Prophylactic treatment for asthma. Taken whenever short acting beta2-agonist (SABA) is taken. | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
66 | Bendamustine HCl 25mg Injection Bendamustine HCl 100mg Injection | Relapsed/Refractory Hodgkin’s lymphoma | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
67 | Bimatoprost 0.01% Ophthalmic Solution* | Lowering of intra-ocular pressure in patients with angle-closure glaucoma | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
68 | Bisoprolol Fumarate 2.5mg Tablet Bisoprolol Fumarate 5mg Tablet | Stable coronary artery disease | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
69 | Bleomycin HCL 15mg Injection | Pleurodesis | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
70 | Brimonidine 0.15% Ophthalmic Solution* | Lowering of intra-ocular pressure in patients with angle-closure glaucoma | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
71 | Budesonide 100mcg/dose Inhaler Budesonide 200mcg/dose Inhaler | Treatment of COPD patients who developed further exacerbations with LABA/LAMA therapy | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
72 | Budesonide 100mcg/dose Inhaler* Budesonide 200mcg/dose Inhaler* | Prophylactic treatment for asthma. Taken whenever short acting beta2-agonist (SABA) is taken. | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
73 | Budesonide 500mcg/2ml Nebuliser Solution | Treatment of post-extubation stridor | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
74 | Cabergoline 0.5mg tablet | Prevention/ relief the symptoms of moderate-severe ovarian hyper stimulation syndrome | - | KKM-55/BPF/103/001/09 Jld. 16(41) | 21/04/2016 | ||||||||||||||||||
75 | Cabergoline 0.5mg Tablet | Acromegaly | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
76 | Cabergoline 0.5mg Tablet | Cushing's syndrome | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
77 | Carbamazepine 200mg tablet | Aggression and associated impulsivity | - | KKM-55/BPF/103/001/09 Jld. 16(41) | 21/04/2016 | ||||||||||||||||||
78 | Carvedilol 6.25mg Tablet Carvedilol 25mg Tablet | Stable coronary artery disease | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
79 | Carvedilol 6.25mg Tablet Carvedilol 25mg Tablet | Post myocardial infarction | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
80 | Cefepime 1g Injection | Infective endocarditis | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
81 | Cefepime 1g Injection | Meningitis | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
82 | Cefoperazone Sodium 1 g Injection | Surgical prophylaxis - urological surgery | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
83 | Ceftazidime 1g Injection* | Adjunct treatment of infective endophthalmitis in combination with other antibiotics (used as intravitreal injection) | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
84 | Ceftazidime 2g & Avibactam 0.5g Injection | i. Treatment of infections outside of the urinary tract caused by New Delhi metallo-β-lactamase (NDM)-producing (or other metallo-β-lactamases) Carbapenem Resistant Enterobacterales (CRE) ii. Treatment of infections caused by DTR Pseudomonas aeruginosa (PAE) in combination with Polymyxin. iii. Treatment of Stenotrophomonas maltophilia infection | KKM.600-34/4/15 Jld. 5 (17) | 23/12/2024 | |||||||||||||||||||
85 | Chloramphenicol 1% Ointment | Prophylaxis for infection on sutured wounds / after procedure | - | KKM-55/BPF/103/001/09 Jld. 16(41) | 21/04/2016 | ||||||||||||||||||
86 | Cholestyramine Resin 4g | Hyperthyroidism when propylthiouracil and carbimazole contraindicated | - | KKM-55/BPF/103/001/09 Jld. 16(41) | 21/04/2016 | ||||||||||||||||||
87 | Cholestyramine Resin 4g | Thyrotoxicosis | KKM.600-34/4/15 Jld. 5 (08) | 06/09/2024 | |||||||||||||||||||
88 | Ciclosporin 25 mg Capsule Ciclosporin 100 mg Capsule Ciclosporin 50mg/ml Injection Ciclosporin 100mg/ml Solution | Hemophagocytic Lymphohistiocytosis (HLH) | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
89 | Ciclosporin 100 mg Capsule, Ciclosporin 25 mg Capsule, Ciclosporin 50 mg/ml Injection | As a second line treatment option of anaemia in young, low risk MDS patients without Chromosome 5q deletion syndrome (del (5q)) | - | KKM.600-34/4/15 Jld. 5 (08) | 06/09/2024 | ||||||||||||||||||
90 | Ciclosporine 25mg capsule, Ciclosporine 100mg capsule | i)Steroid-Dependant or Refractory Ulcerative Colitits in children and adult ii) Stevens Johnson Syndrome iii) Toxic epidermal necrolysis | KKM.600-34/4/15 Jld. 5 (08) | 06/09/2024 | |||||||||||||||||||
91 | Ciclosporine 25mg capsule, Ciclosporine 100mg capsule | Treatment in moderate to severe SLE | KKM.600-34/4/15 Jld. 5 (17) | 23/12/2024 | |||||||||||||||||||
92 | Ciprofloxacin 250 mg Tablet | Surgical prophylaxis - urological surgery | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
93 | Clarithromycin 250mg Tablet | Treatment of Non-tuberculous Mycobacteria (NTM) other than skin & soft tissue (SSTI) NTM | KKM.600-34/4/15 Jld. 5 (17) | 23/12/2024 | |||||||||||||||||||
94 | Clindamycin 300mg Capsule Clindamycin 150mg Injection | Ocular Toxoplasmosis (Toxoplasma gondii) | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
95 | Clofazimine 50mg Capsule* Clofazimine 100mg Capsule* | Treatment of multidrug resistant tuberculosis (MDR-TB) | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
96 | Clonidine 0.025mg Tablet | As an adjunct sedative agent in paediatric patient not sedated despite on maximum use of common sedative agents. | - | KKM.600-34/4/15 Jld. 4 (56) | 14/08/2023 | ||||||||||||||||||
97 | Clonidine 0.025mg Tablet | As an adjunct in paediatric pain management | KKM.600-34/4/15 Jld. 5 (08) | 06/09/2024 | |||||||||||||||||||
98 | Colchicine 0.5mg Tablet | Recurrent Pericarditis | - | KKM.600-34/4/15 Jld. 5 (08) | 06/09/2024 | ||||||||||||||||||
99 | Colchicine 0.5mg Tablet | Chronic coronary syndrome | - | KKM.600-34/4/15 Jld. 5 (08) | 06/09/2024 | ||||||||||||||||||
100 | Conjugated Estrogens 0.625mg/g Cream | Labial adhesion | KKM.600-34/4/15 Jld 5 (33) | 13/08/2025 | |||||||||||||||||||